Molecular Analysis of Cardiovascular Disease: Some Delay due to Gene-Environment Interactions

ABSTRACT

The absence of a clear relation between genotype and phenotype has complicated molecular analyses of the susceptibility to common diseases such as cardiovascular disease. Gene-gene and gene-environment interactions may have biased genetic association studies on cardiovascular disease. In the general population, susceptibility to cardiovascular disease is probably the result of many loci with frequently occurring alleles that have relatively small effects. We hypothesize that addition of mortality analyses to genetic association studies may provide important information on the clinical relevance of molecular findings. We propose to use a parent-offspring model for this purpose: the parents contribute large follow-up and the index cases (offspring) are eliminated from the analyses to remove selection on cardiovascular disease. In particular, indirect estimation of mortality risk has high statistical power and may establish the role of common genetic variation with small effects on cardiovascular disease in the general population. Moreover, the effect of a candidate gene on excess mortality illustrates the quality of such a gene or protein as a novel target for intervention. The results of genetic association studies may have been of little clinical relevance for cardiovascular disease, but we conclude that the methodology still has possibilities for improvements and we propose to use analyses of mortality in a parent-offspring model.

KEYWORDS

All-cause mortality - candidate gene - complex trait - gene-environment interaction - genetic association study - statistical power

REFERENCES

• 1 Centers for Disease Control and Prevention .The Office of Genetics and Disease Prevention. Gene-environment interaction fact sheet. Available at: http://www.cdc.gov/genomics/oldWeb01_16_04/info/files/text/GeneEnviro.pdf Accessed August 2000
• 2 Yamada Y, Izawa H, Ichihara S et al.. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes.  N Engl J Med. 2002;  347 1916-1923
• 3 Glazier A M, Nadeau J H, Aitman T J. Finding genes that underlie complex diseases.  Science. 2002;  298 2345-2349
• 4 Sijbrands E J, Westendorp R G, Paola Lombardi M et al.. Additional risk factors influence excess mortality in heterozygous familial hypercholesterolemia.  Atherosclerosis. 2000;  149 421-425
• 5 Garrod A E. The incidence of alcaptonuria: a study in chemical individuality.  Lancet. 1902;  ii 1616-1620
• 6 Garrod A E. Inborn Errors of Metabolism. Oxford; Oxford University Press 1909
• 7 Vogel F. Clinical consequences of heterozygosity for autosomal recessive diseases.  Clin Genet. 1984;  25 381-415
• 8 Sijbrands E JG, Hoffer M JV, Havekes L M, Frants R R, Smelt A HM, de Knijff P. Severe hyperlipidemia in apolipoprotein E2 homozygotes due to a combined effect of hyperinsulinemia and a SstI polymorphism.  Arterioscler Thromb Vasc Biol. 1999;  19 2722-2729
• 9 Ioannidis J PA, Ntzani E E, Trikalinos T A, Contopoulos-Ioannidis D G. Replication validity of genetic association studies.  Nat Genet. 2001;  29 306-309
• 10 Potter J D. At the interfaces of epidemiology, genetics and genomics.  Nat Rev Genet. 2001;  2 142-147
• 11 Alper J S. Genetic complexity in single gene diseases. No simple link between genotype and phenotype.  BMJ. 1996;  312 196-197
• 12 Sijbrands E JG, Westendorp R GJ, Defesche J C, Smelt A HM, Kastelein J JP. Mortality over two centuries in a large pedigree with familial hypercholesterolaemia.  BMJ. 2001;  322 1019-1023
• 13 Sing C F, Reilly S L. Genetics of common diseases that aggregate, but do not segregate, in families. In: Sing CF, Hanis CL Genetics of Cellular, Individual, Family, and Population Variability New York; Oxford University Press 1993: 140-161
• 14 Jukema J W, van Boven A J, Groenemeijer B et al.. The Asp9 Asn mutation in the lipoprotein lipase gene is associated with increased progression of coronary atherosclerosis. REGRESS Study Group, Interuniversity Cardiology Institute, Utrecht, The Netherlands.  Regression Growth Evaluation Statin Study Circulation. 1996;  94 1913-1918
• 15 Boekholdt S M, Agema W R, Peters R J et al.. Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events.  Circulation. 2003;  107 2416-2421
• 16 Boekholdt S M, Peters R J, de Maat M P et al.. Interaction between a genetic variant of the platelet fibrinogen receptor and fibrinogen levels in determining the risk of cardiovascular events.  Am Heart J. 2004;  147 181-186
• 17 Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results.  Nat Genet. 1995;  11 241-247
• 18 Risch N, Merikangas K. The future of genetic studies of complex human diseases.  Science. 1996;  273 1516-1517
• 19 Spielman R S, McGinnis R E, Ewens W J. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM).  Am J Hum Genet. 1993;  52 506-516
• 20 Bennett S T. Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin minisatellite locus.  Nat Genet. 1995;  9 284-292
• 21 Pritchard J K, Rosenberg N A. Use of unlinked genetic markers to detect population stratification in association studies.  Am J Hum Genet. 1999;  65 220-228